Lucid Diagnostics (LUCD) EBIT (2020 - 2026)
Lucid Diagnostics (LUCD) posted EBIT of -$12.1 million for Q1 2026, up 13.54% on a QoQ basis from -$14.0 million in Q4 2025, and up 2.99% year-over-year from -$11.8 million in Q1 2025.
Lucid Diagnostics (LUCD) EBIT (2020 - 2026) Analysis & Trends
Lucid Diagnostics' EBIT history runs 7 years deep, the most recent figure standing at -$12.1 million for Q1 2026.
- Quarterly EBIT rose 2.99% year-over-year to -$12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.3 million (down 3.18% YoY) and the FY2025 annual result came in at -$49.6 million, down 7.79% from the prior year.
- EBIT was -$12.1 million for Q1 2026 at Lucid Diagnostics, up from -$14.0 million in the prior quarter.
- Across five years, EBIT topped out at -$10.8 million in Q1 2024 and bottomed at -$15.0 million in Q4 2022.
- A 5-year average of -$12.5 million and a median of -$12.1 million in 2026 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT slumped 235.92% — and 2024, when it advanced 24.62%.
- Lucid Diagnostics' EBIT stood at -$15.0 million in 2022, then climbed by 23.52% to -$11.5 million in 2023, then retreated by 8.05% to -$12.4 million in 2024, then dropped by 13.22% to -$14.0 million in 2025, then increased by 13.54% to -$12.1 million in 2026.
- Business Quant data shows LUCD's EBIT at -$12.1 million in Q1 2026, -$14.0 million in Q4 2025, and -$11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -12.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.11 Mn |
| Dec 31, 2025 | -14.01 Mn |
| Sep 30, 2025 | -11.76 Mn |
| Jun 30, 2025 | -11.38 Mn |
| Mar 31, 2025 | -12.49 Mn |
| Dec 31, 2024 | -12.38 Mn |
| Sep 30, 2024 | -11.69 Mn |
| Jun 30, 2024 | -11.19 Mn |
| Mar 31, 2024 | -10.79 Mn |
| Dec 31, 2023 | -11.45 Mn |
| Sep 30, 2023 | -11.13 Mn |
| Jun 30, 2023 | -11.58 Mn |
| Mar 31, 2023 | -14.32 Mn |
| Dec 31, 2022 | -14.98 Mn |
| Sep 30, 2022 | -14.38 Mn |
| Jun 30, 2022 | -14.63 Mn |
| Mar 31, 2022 | -12.27 Mn |
| Dec 31, 2021 | -11.24 Mn |
| Sep 30, 2021 | -6.51 Mn |
| Jun 30, 2021 | -6.02 Mn |